Latest stories on QURE
uniQure: The Market Graded The Wrong Exam
Seeking Alpha64 · neutralanalyst
uniQure assumed with a Buy at UBS
The Fly61 · neutralanalyst
Cedar Grove Capital Q3 2026 Portfolio Update
Seeking Alpha50 · neutralgeneral
uniQure downgraded to Equal Weight from Overweight at Barclays
The Fly38 · neutralanalyst
Stocktwits Pharma Pulse: Roche Faces FDA Decision, Gene-Therapy Stocks Step Into Focus — The Week’s Biotech Watchlist
Stocktwits News58 · neutralproduct/pr
uniQure price target lowered to $48 from $65 at RBC Capital
The Fly34 · bearishanalyst
RBC Capital cuts uniQure stock price target on trial data
Investing.com Analyst Ratings34 · bearishanalyst
Fabry Disease Market Outlook: 6 Upcoming Therapies Set to Influence the Future Market Landscape | DelveInsight
PR Newswire50 · neutralgeneral
UNIQURE INVESTIGATION: QURE Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights
GlobeNewswire34 · bearishgeneral
uniQure: A Speculative Buy After Huntington's Disease Trial's 4-Year Data Update
Seeking Alpha63 · neutralproduct/pr
uniQure Stock Crashed on Its Huntington’s Data. Wall Street’s Price Target Says the Selloff Went Too Far
24/7 Wall St.42 · neutralearnings
uniQure Stock Plunges On 4-Year Data, But The Approval Path Is Intact (Rating Upgrade)
Seeking Alpha56 · neutralanalyst
uniQure price target lowered to $31 from $46 at Goldman Sachs
The Fly34 · bearishanalyst
uniQure Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into uniQure (QURE)
PR Newswire28 · bearishgeneral
QURE Stock Clocks Worst Day In Over 10 Months: Four-Year Huntington’s Data Spooks Investors Despite Stronger Three-Year Filing Data
Stocktwits News32 · bearishproduct/pr
uniQure weakness creates attractive opportunity, says Wells Fargo
The Fly56 · neutralanalyst
RBC says uniQure’s four-year HD data mixed, stock reaction ‘overdone’
The Fly42 · neutralanalyst
uniQure: Another Selloff On 48-Month Huntington Data; I Am (Marginally) Bullish
Seeking Alpha56 · neutralanalyst
uniQure ‘mixed’ four-year data complicates durability case, says H.C. Wainwright
The Fly42 · neutralgeneral
uniQure falls -38.4%
The Fly12 · bearishgeneral
QURE Investor Alert: uniQure Securities Investigation - Kehoe Law Firm, P.C.
GlobeNewswire34 · bearishgeneral
uniQure falls -36.4%
The Fly34 · bearishgeneral
uniQure Shares Fall 64% After 48-Month AMT-130 Huntington’s Disease Trial Update
InvestorsHub22 · bearishearnings